European Institute of Science AB

  • Market Cap: N/A
  • Industry: Electronic Equipment/Instruments
  • ISIN: SE0020357457
SEK
0.34
-0.15 (-31.43%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

22.23 k

Shareholding (Mar 2023)

FII

0.00%

Held by 0 FIIs

DII

100.0%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Electronic Equipment/Instruments

stock-summary
Market cap

SEK Million ()

stock-summary
P/E

0

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.07

stock-summary
Return on Equity

-50.89%

stock-summary
Price to Book

0.00

Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Sep 2024)
Net Profit:
-1 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-89.94%
0%
-89.94%
6 Months
-87.46%
0%
-87.46%
1 Year
-96.64%
0%
-96.64%
2 Years
-99.33%
0%
-99.33%
3 Years
-99.32%
0%
-99.32%
4 Years
-99.66%
0%
-99.66%
5 Years
-99.71%
0%
-99.71%

European Institute of Science AB for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
10.26%
EBIT Growth (5y)
2.68%
EBIT to Interest (avg)
-2.63
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.07
Sales to Capital Employed (avg)
0.29
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
Industry P/E
Price to Book Value
NA
EV to EBIT
0.14
EV to EBITDA
0.14
EV to Capital Employed
-0.07
EV to Sales
-0.35
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-50.89%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2023stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Strategic Entities

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 0 Foreign Institutions (0%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2024 is 200.00% vs 0.00% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2024 is 14.29% vs 0.00% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.30",
          "val2": "0.10",
          "chgp": "200.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.60",
          "val2": "-0.70",
          "chgp": "14.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.60",
          "val2": "-0.70",
          "chgp": "14.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-2,288.80%",
          "val2": "-6,428.60%",
          "chgp": "413.98%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2023 is 20.00% vs 0.00% in Dec 2022",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2023 is 0.00% vs -8.00% in Dec 2022",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'23",
        "Dec'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.60",
          "val2": "0.50",
          "chgp": "20.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-2.80",
          "val2": "-2.70",
          "chgp": "-3.70%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-2.70",
          "val2": "-2.70",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-4,612.10%",
          "val2": "-5,160.10%",
          "chgp": "54.80%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Sep'24 - YoYstock-summary
Sep'24
Sep'23
Change(%)
Net Sales
0.30
0.10
200.00%
Operating Profit (PBDIT) excl Other Income
-0.60
-0.70
14.29%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-0.60
-0.70
14.29%
Operating Profit Margin (Excl OI)
-2,288.80%
-6,428.60%
413.98%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Sep 2024 is 200.00% vs 0.00% in Sep 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Sep 2024 is 14.29% vs 0.00% in Sep 2023

Annual Results Snapshot (Consolidated) - Dec'23stock-summary
Dec'23
Dec'22
Change(%)
Net Sales
0.60
0.50
20.00%
Operating Profit (PBDIT) excl Other Income
-2.80
-2.70
-3.70%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-2.70
-2.70
Operating Profit Margin (Excl OI)
-4,612.10%
-5,160.10%
54.80%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2023 is 20.00% vs 0.00% in Dec 2022

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2023 is 0.00% vs -8.00% in Dec 2022

stock-summaryCompany CV
About European Institute of Science AB stock-summary
stock-summary
European Institute of Science AB
Electronic Equipment/Instruments
European Institute of Science AB (EURIS) is a Sweden-based commercial research center. The Company, through its wholly owned subsidiary, ScienceHouse Lund AB is engaged in the research, development, manufacturing, sales and marketing of medical technology, health care, cosmetics and personal care, biotechnology, energy, education and entertainment products and methods. Additionally, it is engaged in the investment in high-technology companies, as well as in leasing and management of properties. As of December 31, 2011, the Company’s investments and project royalties included LifeAssays AB (publ), Biotech-IgG AB and Implementa Hebe AB (publ). The Company’s products include liquid chromatography equipment for affinity purification of proteins and antibodies, and a range of products obtained from pooled human or animal plasma.
Company Coordinates stock-summary
Company Details
Ideongatan 1A , LUND None : 223 70
stock-summary
Tel: 46 46 2862230
stock-summary
Registrar Details